MedQuest wins US patent for artificial heart technology
This article was originally published in Clinica
MedQuest Products has gained a US patent covering the technology incorporated in its HeartQuest long-term artificial heart device. The device uses a magnetically suspended blood pump with no friction-based internal parts, which the company hopes will offer improved reliability and longevity. Salt-Lake City, Utah-based MedQuest told Clinica that the product is being designed for a 10-year lifespan.